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Frequency and Significance of Cervicomediastinal Lymph Node
Metastases in Medullary Thyroid Carcinoma: Results of a
Compartment-Oriented Microdissection Method

Henning Dralle,* Iris Damm,* Georg Friedrich Wilhelm Scheumann,* Jorg Kotzerke,^
and Eckart Kupsch*

The frequency and significance of cervicomediastinal lymph node metastases have been investigated
in 82 medullaiy thyroid carcinoma (MTC) patients retrospectively comparing two surgical techniques of lymph node dissection: selective lymphadenectomy (n = 63] versus compartment-oriented
microdissection (n = 35). No positive correlation was observed between primary tumor size and the
number of lymph node metastases. Inpatients with lymph node metastases proven histologically, 42%
showed only cervical involvement (35% unilateral—type A, 7% bilateral—type B) and 22%
cervicomediastinal lymph node involvement (15% cervico-unilateral and mediastinal—type C. 7%
cervicobilateral and mediastinal—type D). Biochemical cure was 83% in node-negative patients but
only 21% in node-positive patients. In node-positive MTC. calcitonin normalization was achieved in
none with bilateral lymph node involvement but only in those unilateral lymph node metastases (31%
in type A, 17% in type C). Survival and biochemical cure are significantly improved by application of
the compartment-oriented microdissection method more .so at primary surgeiy than at reoperation.
(Henry Ford Hosp MedJ 1992:40:264-7)

L

ymph node metastases have been proven to be the most important prognostic factors in sporadic and hereditary medullary thyroid carcinoma (MTC) (1,2). A recent study demonstrated that the rate of node-positive patients was significantly
lower in tumors smaller than 1 cm in diameter compared to
larger tumors. However, in the entire group of MTC patients, no
positive correlation was observed between primary tumor size
and the occurrence and number of lymph node metastases (3). In
hereditary MTC, central lymph node metastases have been observed even in patients with primary tumors not exceeding 5
mm in diameter (4).
In addition to the frequent and primary tumor size-independent occurrence of lymph node metastases, MTC tends to spread
beyond the central area of the neck into the lateral and superior
mediastinal lymph node compartments as well as to distant organs by developing multiple micrometastases. Important biological characteristics of MTC include not only its detectability
by sensitive calcitonin (CT) studies (5-7) and imaging procedures (8) but also its tendency to metastasize early to cervicocentral nodes.
Due to the ineffectiveness of adjuvant treatment modalities
(9,10), surgery is regarded as the treatment of choice in MTC.
However, with growing recognition of the regional and distant
micrometastatic process, standardization of surgical technique
for lymph node dissection has been controversial as to the extent
of lymph node removal which is indicated for different tumor
sizes and/or macroscopic or microscopic involvement of regional lymph nodes (11-15). Along with the Goteborg group of
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Tised et al (11), we developed a compartment-oriented microdis.section (COMD) method of cervicomediastinal lymph node
dissection aimed at the following: 1) the en block microdissection of anatomically defined compartments, and 2) quantitative
analysis of the tumor involved and excised lymph nodes (3,4).
In the present study we analyzed the frequency and location of
regional lymph node metastases in sporadic and hereditary
MTC, the biochemical cure after surgery relative to lymph node
involvement, and the biochemical cure and survival after
COMD versus selective lymphadenectomy (SLA).

Patients and Methods
This retrospective study concems 82 MTC patients operated
on initially or subsequendy at the Medical School of Hannover's surgery department from 1970 to 1990 including 35 patients operated on by the COMD method since 1986. Twentyfive patients belonging to 11 families had the hereditary form of
MTC (23 with multiple endocrine neoplasia type 2A [MEN 2A]

Submitted for publication: November 8. 1991.
Accepted for publication; January 27, 1992.
*Klinik fur Abdominal-und Transplantationschirurgie der Medlzinischen Hochschule
Hannover, Hannover, Germany.
tAbteilung Nuklearmedizin und klinische Biophysik der Medlzinischen Hochschule
Hannover, Hannover, Germany.
tlnstitut fur Pathologie der Medlzinischen Hochschule Hannover, Hannover. Germany.
Address correspondence to Prof. Dr. Dralle. Klinik fur Abdomin.aI-und Transplantationschirurgie der Medlzinischen Hochschule Hannover, Konstanty-Gutschow-Str. 8, 3000
Hannover 61, Germany.

Cervicomediastinal Lymph Node Metastases in MTC—Dralle el al

Table 2
Biochemical Cure Rate Regarding Type of Lymph
Node Metastases in 82 MTC Patients*

Table 1
Primary Tiimor Size and Types of Lymph Node
Metastases in 82 MTC Patients*
No Lymph Node

Primary Tumor
Size (cm)t

11

Metastases (%)

< 1
1.0-1.9
2.0-3.9
>4
Total

10
15
32
25
S2

7(70)
9(60)
11 (34)
2(8)
29 (35)

Type B

TypeC

(%)

(%)

(%)

2(20)
5 (33)
13(41)
9(36)
29 (35)

0
0
3(9)
3(12)
6(7)

Type A

1(10)
0
4(13)
7(28)
12(15)

Type D

(%)
0
1 (7)
1(3)
4(16)
6(7)

No Lymph Node
Metastasest

Type A

Type B

Type C

Type D

24/29
(82.7%)

<V2')
(31.0%)

(1/6

2/12
(16.7%)

0/6

•^Patients with normal stimulated calcitonin testing at the time of actual follow-up.
t A four-compartmentectomy has been effected only in Type C and Type D MTC.

*Definition of lymph node involvement during the entire observation period of the patients. A four-compartmentectomy has been effected only in Type C and Type D MTC.
tLargest diameter.

and two with MEN 2B), and 57 had sporadic MTC. All patients
received regular clinical follow-up until June 1991. Eighteen
patients died due to metastasizing MTC, and two additional patients died as a result of other nontumor-related causes. The
probability of survival was analyzed using estimated survival
curves (16), employing the Mantel-Cox test and the generalized
Wilcoxon test (17). Histological classification of MTC was performed according to the World Healdi Organization typing of
thyroid tumors (18), and staging of primary tumors was done according to the Tumor-Node-Metastasis classification for malignant tumors of the UICC (19). Stimulated CT testing was performed by intravenous bolus injection of 0.5 p.g pentagastrin/kg
body weight and by obtaining peripheral blood levels at 0, 2,
and 5 minutes after injection.
The compartment definition of cervicomediastinal lymph
nodes and the definition of types of regional lymph node metastases in MTC is used as recently described (3,4). Compartment
1 represents the central cervical lymph node system right and
left from the trachea between the trachea and carotid sheath and
from the hyoid bone down to the brachiocephalic vein. Compartments 2 and 3 represent the right and left cervicolateral
lymph node system between the carotid sheath and trapezoid
muscle, from the subclavian vein up to the hypoglossal nerve,
anterior, posterior, and between the fascicles of the cervical
plexus. Compartment 4 represents the mediastinal lymph node
system on both sides of the trachea, from the left brachiocephalic vein down to the tracheal bifurcation within the anterior and
posterior part of the upper mediastinum. The types of cervicomediastinal lymph node metastases in MTC have been defined as: 1) type A: MTC with unilateral lymph node metastases
in the neck, confined to the perithyroidal, paratracheal, and/or
cervicolateral lymph nodes; 2) type B: MTC with bilateral
lymph nodes in the neck, including the contralateral side of the
primary tumor; 3) type C: MTC with lymph node metastases on
one side of the neck (including paratracheal lymph nodes on
both sides) and within the upper mediastinum but without metastases contralateral to the cervicolateral compartment of the
primary tumor; and 4) type D: MTC with lymph node metastases in all four cervicomediastinal compartments.
SLA, performed as the standard technique of lymph node dissection for MTC from 1970 to 1986, consists of the removal of
lymph nodes or groups of lymph nodes with macroscopic tumor
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involvement. In contrast, the COMD method is achieved by the
en bloc removal of anatomically defined compartments of
lymph nodes, adipose tissue, and connective tissue with the aid
of magnification. Vital structures, muscles, vessels, and nerves
are identified and preserved. The mediastinal compartment is
removed by a transstemal approach. The number of lymph
nodes excised and the number of lymph nodes involved by the
tumor are documented quantitatively by histological analysis.

Results
The primary tumor size and the types of lymph node metastases in 82 MTC patients are shown in Table 1. As tumor size increased, the number of MTC patients without regional lymph
node metastases decreased. Eighteen patients underwent a
transstemal dissection of the superior mediastinal lymph node
compartment. Although type C and type D lymph node involvement were predominantly observed in locally metastatic primary tumors with diameters exceeding 4 cm in diameter ( I I
[44%] of 25 patients), these types of lymph node involvement
were documented also in 6 (13%) of 47 patients with T2 tumors.
Type C lymph node metastases (i.e., cervico-undateral and mediastinal lymph node involvement) could be shown in a total of
12 (15%) of 82 MTC patients (11 with sporadic MTC and 1 with
hereditary MTC). Type D lymph node metastases (cervicobilateral and mediastinal lymph node involvement) were found in
1 (4%) of 25 hereditary and in 5 (9%) of 57 sporadic MTC patients.
The results of lymph node surgery relative to pentagastrinstimulated CT levels are shown in Table 2. The data include the
whole series of MTC patients having SLA or the COMD
method. A total of 83% of node-negative MTC patients, compared to 21 % of node-positive patients, had negative pentagastrin stimulation tests. In the case of synchronous or metachronous lymph node metastases, CT normalization was achieved in
only 13% of patients if more than one operation was necessary
compared to 33% of patients after adequate first surgery. Even
after extensive cervical or cervicomediastinal compartmentectomy in type B and type D MTC, normalization of CT levels was
not attained.
Biochemical results with the two types of surgical technique
of lymph node dissection (SLA versus COMD) are given in Ta-
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Table 3
Biochemical Cure After Selective Lymphadenectomy Versus Compartment-Oriented
Microdissection in 70 Patients with Node-Positive MTC*
COMD

SLA
Lymph Node

First Operation

Statust
NO
Nl
Total

Reoperation

Firsl Operation

Reoperation

(%)

(%)

(%)

(%)

2/2
(100)
3/21
(14)
5/23
(22)

2/2
(IOO)
2/38
(5)
4/40
(10)

10/10
(100)
4/10
(40)
14/20
(70)

1/1
(100)
3/14
(21)
4/15
(27)

*Patients with normal stimulated calcitonin testing at the time of follow-up. Twelve ofthe entire group of 82 MTC patients had
no lymph node surgery,
t According to the UlCC classification of 1987.
SLA = selective lymphadenectomy (n = 63): COMD = compartment-oriented microdissection (n = 35).

Table 4
Present Surgical Strategy to MTC
Indications
All MTC
Cervicounilateral LNM
Cervicobilateral LNM
Cervicounilateral and
mediastinal LNM
Cervicobilateral and
mediastinal LNM

Type of LNM*

Extent of Surgeryt

A
B

TT.Cl
TT.CI 4-C2/3
TT,C1-C3

C

TT,C1-C4

D

TT, CI-C4

*LNM = lymph node metastases (for definition of types see Patients and Methods section).
tTT = total thyroidectomy (for C1, 2, 3, 4 definifion of compartments see Patients and
Methods section).

ble 3. In node-positive MTC, normalization of pentagastrinstimulated serum CT levels increased from 14% to 40% after
first surgery and from 5% to 21% after reoperative surgery if the
COMD method was performed.
Survival data for our MTC patients revealed a significandy
better prognosis for patients without lymph node metastases
compared to those with lymph node metastases (Figure, left
panel). Within node-positive groups, those with mediastinal
lymph node metastases had the most unfavorable prognosis.
The survival data of node-positive MTC patients were significandy improved by the COMD technique as compared to the results obtained after SLA (Figure, right panel).

Discussion
This study confirms earlier studies demonstrating the significance of lymph node metastases as a dominating prognostic factor in MTC (I). In addition, this and other reports have shown
that more radical surgery regarding cervicomediastinal lymph
node dissection using microdissection techniques may improve
the recurrence rate and increase survival without increasing surgicady related morbidity (3,4,11).
The COMD technique was originally described by Tisell et al
in 1986 (11). At that time our own technique of lymph node dis-
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section changed to more extensive procedures due to disappointing results of SLA in node-positive MTC. Because of the
observed micrometastatic lymphangitic spread of MTC, we developed a compartment-oriented approach to node-positive
MTC defined by the types of lymph node metastases found in
patients with cervicomediastinal lymph node metastases (Table
4). With this strategy, all patients with MTC, regardless of the
presence or absence of lymph node metastases, undergo a total
thyroidectomy and rnicrodissection of the cervicocentral compartment. In the case of macroscopic or microscopic evidence of
lymph node metastases, unilateral (if lymph node metastases are
confined to one side of the neck) or bilateral (with lymph node
involvement on both sides of the tracheal axis) microdissection
ofthe cervicolateral compartment is added.
By meticulous analysis of three- and four-compartmentectomy tissue specimens, it has been proven that superior mediastinal lymph node involvement occurs not only in patients with
bilateral cervicolateral lymph node metastases but also in some
patients with unilateral cervical lymph node metastases. This
type (type C) of lymphangic spread has been observed in 19% of
sporadic and 4% of hereditary MTC in our series of 82 MTC patients. In two of 12 patients with type C lymph node metastases,
a normalization of CT levels resulted after the four-compartmentectomy procedure, corresponding to the results achieved in
patients with cervico-unilateral (type A) and cervicobilateral
lymph node metastases of MTC (type B) (Table 2). Nine (31%)
of 29 patients with type A lymph node metastases have been observed to be biochemically cured, although this has not happened with any of the six cases of type B. Since all ofthe patients
with type B lymph node metastases had only a cervical lymph
node dissection, it is suspected that at least some had microscopic foci within the superior mediastinum or elsewhere.
Due to the current detection timits of imaging methods (8) as
well as venous catheterization procedures (20), the frequency
and significance of superior mediastinal lymph node metastases
and the exact indications for transstemal mediastinectomy remain to be investigated by further interdisciplinary surgical,
pathological, and localization studies so that further improvement in treatment results will be attained.
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0/34 COMD
1/29 no LNM

35 cervical LNM

8/18 mediastinal LNM

18/35 SLA

p<0.005

—

nr

G

8

T
10

12

1*

Years after surgery

6

1

1

1

8

10

12

14

Years after surgery

pifTure—Prognostic significance of lymph node status and technique of lymphadenectomy in 82 MTC patients (LNM = lymph node
metastases, COMD = compartment-oriented microdissection, SLA = selective lymphadenectomy).
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